Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1381-452-specific antibody titersHannes Vietzen, Elisabeth Puchhammer-Stöckl, Charlotte Pistorius et al.|Nature Communications|2025Cited by 16
Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory DiseasesHannes Vietzen, Paulus Rommer, Laura M. Kühner et al.|JAMA Neurology|2026Cited by 0
Early immune activation in the prediagnostic phases of immune-mediated neurological diseasesHannes Vietzen, Raphael Reinecke, Jan Nolte et al.|medRxiv|2026Cited by 0